1915

From asymptomatic to critical illness - different clinical manifestations of COVID-19 in children

Abstract: The global pandemic infectious disease that was named the new coronavirus disease (COVID 19), spread throughout the world, causing a major public health emergency. The causative virus of COVID-19, called SARS CoV-2, can infect all age groups. Various clinical signs and symptoms have been observed in neonates, children, and adolescents during the COVID-19 outbreak. The clinical manifestations of COVID-19 might be different due to the medical conditions and comorbid status in elderly and pediatric patients. The rise in cases among children has been reported during the COVID-19 pandemic. Although infected children generally appear to be asymptomatic or have only mild symptoms, COVID-19 in children may also involve a wide spectrum of clinical manifestations ranging from asymptomatic carriers to life-threatening and fatal diseases, as COVID-19 is a systemic disease that can affect multiple organs. Due to the lack of knowledge in the current literature, it is necessary to describe the atypical clinical features, including extrapulmonary manifestations, in pediatric patients with COVID-19. This review is conducted to identify knowledge gaps regarding the broad spectrum of clinical signs and symptoms of children with COVID-19.Key words: COVID-19, multisystem inflammatory syndrome in children (MIS-C), SARS CoV-2, children

PDF

___

1. Zhu N, Zhang D, Wang W, Li X, Yang B et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. The New England Journal of Medicine 2020;382(8):727- 733. doi:10.1056/NEJMoa2001017
2. Cui X, Zhao Z, Zhang T, Guo W, Guo W et al. A systematic review and meta-analysis of children with coronavirus disease 2019 (COVID-19). Journal of Medical Virology 2021;93(2):1057-1069. doi:10.1002/jmv.26398
3. Dong Y, Mo X, Hu Y, Qi X, Jiang F et al. Epidemiology of COVID-19 Among Children in China. Pediatrics 2020;145(6):e20200702. doi:10.1542/peds.2020-0702
4. Liu X, Tang J, Xie R, Li W, Chen J, et al. Clinical and Epidemiological Features of 46 Children <1 Year Old With Coronavirus Disease 2019 in Wuhan, China: A Descriptive Study. The Journal of Infectious Diseases 2020;222(8):1293- 1297. doi:10.1093/infdis/jiaa472
5. Pousa PA, Mendonça TSC, Oliveira EA, Simões-E-Silva AC. Extrapulmonary manifestations of COVID-19 in children: a comprehensive review and pathophysiological considerations. Jornal De Pediatria 2021;97(2):116-139. doi:10.1016/j.jped.2020.08.007
6. Martins MM, Prata-Barbosa A, da Cunha AJLA. Update on SARS-CoV-2 infection in children. Paediatrics and International Child Health 2021;41(1):56-64.doi:10.1080/2046 9047.2021.1888026
7. Karbuz A, Akkoc G, Bedir Demirdag T, Yilmaz Ciftdogan D, Ozer A et al. Epidemiological, Clinical, and Laboratory Features of Children With COVID-19 in Turkey. Frontiers in Pediatrics 2021;9:631547. doi:10.3389/fped.2021.631547
8. Stokes EK, Zambrano LD, Anderson KN, Marder EP, Raz KM et al. Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020. MMWR Morbidity and Mortality Weekly Report 2020;69(24):759-765. doi:10.15585/ mmwr.mm6924e2
9. Irfan O, Muttalib F, Tang K, Jiang L, Lassi ZS et al. Clinical characteristics, treatment and outcomes of paediatric COVID-19: a systematic review and meta-analysis. Archives of Disease in Childhood 2021;106(5):440-448. doi:10.1136/ archdischild-2020-321385
10. Liguoro I, Pilotto C, Bonanni M, Ferrari ME, Pusiol A et al. SARS-COV-2 infection in children and newborns: a systematic review. European Journal of Pediatrics 2020;179(7):1029-1046. doi:10.1007/s00431-020-03684-7
11. Mark EG, Golden WC, Gilmore MM, Sick-Samuels A, Curless MS et al. Community-Onset Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Young Infants: A Systematic Review. The Journal of Pediatrics 2021;228:94-100. e3. doi:10.1016/j.jpeds.2020.09.008
12. Spoulou V, Noni M, Koukou D, Kossyvakis A, Michos A. Clinical characteristics of COVID-19 in neonates and young infants. European Journal of Pediatrics 2021;180(9):3041-3045. doi:10.1007/s00431-021-04042-x
13. Ng KF, Bandi S, Bird PW, Wei-Tze Tang J. COVID-19 in Neonates and Infants: Progression and Recovery. The Pediatric Infectious Disease Journal 2020;39(7):e140-e142. doi:10.1097/ INF.0000000000002738
14. Samuel S, Friedman RA, Sharma C, Ganigara M, Mitchell E et al. Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCRpositive SARS-CoV-2 infection, including drug-induced changes in the corrected QT interval. Heart Rhythm 2020;17(11):1960-1966. doi:10.1016/j.hrthm.2020.06.033
15. Wu L, O’Kane AM, Peng H, Bi Y, Motriuk-Smith D, Ren J. SARSCoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management. Biochemical Pharmacology 2020;178:114114. doi:10.1016/j.bcp.2020.114114
16. Dimopoulou D, Spyridis N, Dasoula F, Krepis P, Eleftheriou E et al. Pericarditis as the Main Clinical Manifestation of COVID-19 in Adolescents. The Pediatric Infectious Disease Journal 2021;40(5):e197-e199. doi:10.1097/INF.0000000000003096
17. Simpson M, Collins C, Nash DB, Panesar LE, Oster ME. Coronavirus Disease 2019 Infection in Children with PreExisting Heart Disease. The Journal of Pediatrics 2020;227:302- 307.e2. doi:10.1016/j.jpeds.2020.07.069
18. Panjabi AL, Foster RC, McCarthy AM, Shah SK, Al-Wahab H et al. Pulmonary Embolism as the Initial Presentation of Coronavirus Disease 2019 in Adolescents. The Pediatric Infectious Disease Journal 2021;40(5):e200-e202.doi:10.1097/ INF.0000000000003106
19. Zachariah P, Johnson CL, Halabi KC, Ahn D, Sen AI et al. Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children’s Hospital in New York City, New York. JAMA pediatrics 2020;174(10):e202430. doi:10.1001/jamapediatrics.2020.2430
20. Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetologica 2010;47(3):193-199. doi:10.1007/s00592-009- 0109-4
21. Liu F, Long X, Zhang B, Zhang W, Chen X et al. ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2020;18(9):2128- 2130.e2. doi:10.1016/j.cgh.2020.04.040
22. Paz L, Eslava E, Ribes M, Mayer EF. Acute Pancreatitis in a Teenager With SARS-CoV-2 Infection. The Pediatric Infectious Disease Journal 2021;40(4):e161-e162. doi:10.1097/ INF.0000000000003046
23. Perez A, Kogan-Liberman D, Sheflin-Findling S, Raizner A, Ahuja KL et al. Presentation of Severe Acute Respiratory Syndrome-Coronavirus 2 Infection as Cholestatic Jaundice in Two Healthy Adolescents. The Journal of Pediatrics 2020;226:278-280. doi:10.1016/j.jpeds.2020.07.054
24. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK et al. Angiotensinconverting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003;426(6965):450-454. doi:10.1038/ nature02145
25. Zhao B, Ni C, Gao R, Wang Y, Yang L et al. Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids. Protein Cell 2020;11(10):771-775. doi:10.1007/s13238-020-00718-6
26. Cui Y, Tian M, Huang D, Wang X, Huang Y, et al. A 55-DayOld Female Infant Infected With 2019 Novel Coronavirus Disease: Presenting With Pneumonia, Liver Injury, and Heart Damage. The Journal of Infectious Diseases 2020;221(11):1775- 1781. doi:10.1093/infdis/jiaa113
27. Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. Journal of Neurology 2021;268(4):1133-1170. doi:10.1007/s00415-020-10124-x
28. LaRovere KL, Riggs BJ, Poussaint TY, Young CC, Newhams MM et al. Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome. JAMA Neurology 2021;78(5):536- 547. doi:10.1001/jamaneurol.2021.0504
29. Lai CC, Ko WC, Lee PI, Jean SS, Hsueh PR. Extra-respiratory manifestations of COVID-19. International Journal of Antimicrobial Agents 2020;56(2):106024. doi:10.1016/j. ijantimicag.2020.106024
30. Panda PK, Sharawat IK, Panda P, Natarajan V, Bhakat R et al. Neurological Complications of SARS-CoV-2 Infection in Children: A Systematic Review and Meta-Analysis. Journal of Tropical Pediatrics 2021;67(3):fmaa070. doi:10.1093/tropej/ fmaa070
31. Lu X, Zhang L, Du H, Zhang J, Li YY et al. SARS-CoV-2 Infection in Children.The New England Journal of Medicine 2020;382(17):1663-1665. doi:10.1056/NEJMc2005073
32. Parri N, Lenge M, Buonsenso D; Coronavirus Infection in Pediatric Emergency Departments (CONFIDENCE) Research Group. Children with Covid-19 in Pediatric Emergency Departments in Italy. The New England Journal of Medicine 2020;383(2):187-190. doi:10.1056/NEJMc2007617
33. Fernandez-Nieto D, Jimenez-Cauhe J, Suarez-Valle A, MorenoArrones OM, Saceda-Corralo D et al. Characterization of acute acral skin lesions in nonhospitalized patients: A case series of 132 patients during the COVID-19 outbreak. Journal of the American Academy of Dermatology 2020;83(1):e61-e63. doi:10.1016/j.jaad.2020.04.093
34. Torrelo A, Andina D, Santonja C, Noguera-Morel L, BascuasArribas M et al. Erythema multiforme-like lesions in children and COVID-19. Pediatric Dermatology 2020;37(3):442-446. doi:10.1111/pde.14246
35. Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Translational research : The Journal of Laboratory and Clinical Medicine 2020;220:1-13. doi:10.1016/j.trsl.2020.04.007
36. Colmenero I, Santonja C, Alonso-Riaño M, Noguera-Morel L, Hernández-Martín A et al. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases. The British Journal of Dermatology 2020;183(4):729-737. doi:10.1111/bjd.19327
37. Castelo-Soccio L, Lara-Corrales I, Paller AS, Bean E, Rangu S et al. Acral Changes in pediatric patients during COVID 19 pandemic: Registry report from the COVID 19 response task force of the society of pediatric dermatology (SPD) and pediatric dermatology research alliance (PeDRA). Pediatric Dermatology 2021;38(2):364-370. doi:10.1111/pde.14566
38. Loon SC, Teoh SC, Oon LL, Se-Thoe SY, Ling AE et al. The severe acute respiratory syndrome coronavirus in tears. The British Journal of Ophthalmology 2004;88(7):861-863. doi:10.1136/ bjo.2003.035931
39. Valente P, Iarossi G, Federici M, Petroni S, Palma P et al. Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2020;24(4):212-215. doi:10.1016/j.jaapos.2020.05.002
40. Ma N, Li P, Wang X, Yu Y, Tan X et al. Ocular Manifestations and Clinical Characteristics of Children With LaboratoryConfirmed COVID-19 in Wuhan, China. JAMA ophthalmology 2020;138(10):1079-1086. doi:10.1001/jamaophthalmol.2020.3690
41. Zhang L, Peres TG, Silva MVF, Camargos P. What we know so far about Coronavirus Disease 2019 in children: A meta-analysis of 551 laboratory-confirmed cases. Pediatric Pulmonology 2020;55(8):2115-2127. doi:10.1002/ppul.24869
42. Stewart DJ, Hartley JC, Johnson M, Marks SD, du Pré P, Stojanovic J. Renal dysfunction in hospitalised children with COVID-19. The Lancet. Child & adolescent health 2020;4(8):e28-e29. doi:10.1016/ S2352-4642(20)30178-4
43. Bhopal SS, Bagaria J, Olabi B, Bhopal R. Children and young people remain at low risk of COVID-19 mortality. The Lancet. Child & adolescent health 2021;5(5):e12-e13. doi:10.1016/S2352- 4642(21)00066-3
44. García-Salido A, Leoz-Gordillo I, Martínez de Azagra-Garde A, Nieto-Moro M, Iglesias-Bouzas MI et al. Children in Critical Care Due to Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Experience in a Spanish Hospital. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 2020;21(8):e576-e580. doi:10.1097/ PCC.0000000000002475
45. Ozcan S, Emeksiz S, Perk O, Uyar E, Kanik Yüksek S. Severe Coronavirus Disease Pneumonia in Pediatric Patients in a Referral Hospital. Journal of Tropical Pediatrics 2021;67(3):fmab052. doi:10.1093/tropej/fmab052
46. Shekerdemian LS, Mahmood NR, Wolfe KK, Riggs BJ, Ross CE et al. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. JAMA pediatrics 2020;174(9):868-873. doi:10.1001/jamapediatrics.2020.1948
47. Bixler D, Miller AD, Mattison CP, Taylor B, Komatsu K et al. SARS-CoV-2-Associated Deaths Among Persons Aged <21 Years - United States, February 12-July 31, 2020. MMWR. Morbidity and Mortality Weekly Report. 2020;69(37):1324- 1329. doi:10.15585/mmwr.mm6937e4
48. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395(10229):1033-1034. doi:10.1016/S0140-6736(20)30628-0
49. Yonker LM, Neilan AM, Bartsch Y, Patel AB, Regan J et al. Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune Responses. The Journal of Pediatrics 2020;227:45-52.e5. doi:10.1016/j.jpeds.2020.08.037
50. Brodin P. Why is COVID-19 so mild in children?. Acta Paediatrica 2020;109(6):1082-1083. doi:10.1111/apa.15271
51. Zimmermann P, Curtis N. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Archives of Disease in Childhood 2020 ;archdischild-2020-320338. doi:10.1136/ archdischild-2020-320338
52. Hyde Z. Difference in SARS-CoV-2 attack rate between children and adults may reflect bias. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021;ciab183. doi:10.1093/cid/ciab183
53. Kim L, Whitaker M, O’Halloran A, Kambhampati A, Chai SJ et al. Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 1-July 25, 2020. MMWR. Morbidity and Mortality Weekly Report 2020;69(32):1081-1088. doi:10.15585/mmwr.mm6932e3
54. Chiotos K, Hayes M, Kimberlin DW, Jones SB, James SH et al. Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2. Journal of the Pediatric Infectious Diseases Society 2021;10(1):34-48. doi:10.1093/jpids/piaa115
55. Götzinger F, Santiago-García B, Noguera-Julián A, Lanaspa M, Lancella L et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. The Lancet. Child & adolescent health 2020;4(9):653-661. doi:10.1016/ S2352-4642(20)30177-2
56. Newman AM, Jhaveri R, Patel AB, Tan TQ, Toia JM et al. Trisomy 21 and Coronavirus Disease 2019 in Pediatric Patients. The Journal of Pediatrics 2021;228:294-296. doi:10.1016/j. jpeds.2020.08.067
57. Bellino S, Punzo O, Rota MC, Del Manso M, Urdiales AM et al. COVID-19 Disease Severity Risk Factors for Pediatric Patients in Italy. Pediatrics 2020;146(4):e2020009399. doi:10.1542/ peds.2020-009399
58. Parri N, Lenge M, Cantoni B, Arrighini A, Romanengo M et al. COVID-19 in 17 Italian Pediatric Emergency Departments. Pediatrics 2020;146(6):e20201235. doi:10.1542/ peds.2020-1235
59. McMichael TM, Clark S, Pogosjans S, Kay M, Lewis J et al. COVID-19 in a Long-Term Care Facility - King County, Washington, February 27-March 9, 2020. MMWR Morbidity and Mortality Weekly Report 2020;69(12):339-342. Published 2020 Mar 27. doi:10.15585/mmwr.mm6912e1
60. Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, et al. Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020;71(15):896-897. doi:10.1093/cid/ciaa415
61. Kass DA, Duggal P, Cingolani O. Obesity could shift severe COVID-19 disease to younger ages. Lancet 2020;395(10236):1544-1545. doi:10.1016/S0140- 6736(20)31024-2
62. Chao JY, Derespina KR, Herold BC, Goldman DL, Aldrich M,et al. Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City. The Journal of Pediatrics 2020;223:14-19.e2. doi:10.1016/j. jpeds.2020.05.006
63. DeBiasi RL, Song X, Delaney M, Bell M, Smith K et al. Severe Coronavirus Disease-2019 in Children and Young Adults in the Washington, DC, Metropolitan Region. The Journal of Pediatrics 2020;223:199-203.e1. doi:10.1016/j. jpeds.2020.05.007
64. Ogden CL, Carroll MD, Fakhouri TH, Hales CM, Fryar CD et al. Prevalence of Obesity Among Youths by Household Income and Education Level of Head of Household - United States 2011-2014. MMWR Morbidity and Mortality Weekly Report 2018;67(6):186-189. doi:10.15585/mmwr.mm6706a3
65. González-Dambrauskas S, Vásquez-Hoyos P, Camporesi A, Díaz-Rubio F, Piñeres-Olave BE et al. Pediatric Critical Care and COVID-19. Pediatrics 2020;146(3):e20201766. doi:10.1542/peds.2020-1766
66. Boulad F, Kamboj M, Bouvier N, Mauguen A, Kung AL. COVID-19 in Children With Cancer in New York City. JAMA oncology 2020;6(9):1459-1460. doi:10.1001/ jamaoncol.2020.2028
67. Pathak EB, Salemi JL, Sobers N, Menard J, Hambleton IR. COVID-19 in Children in the United States: Intensive Care Admissions, Estimated Total Infected, and Projected Numbers of Severe Pediatric Cases in 2020. Journal of Public Health Management and Practice : JPHMP 2020;26(4):325-333. doi:10.1097/PHH.0000000000001190
68. Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. The New England Journal of Medicine 2020;383(4):334-346. doi:10.1056/NEJMoa2021680
69. Godfred-Cato S, Bryant B, Leung J, Oster ME, Conklin L et al. COVID-19-Associated Multisystem Inflammatory Syndrome in Children - United States, March-July 2020. MMWR Morbidity and Mortality Weekly Report 2020;69(32):1074-1080. doi:10.15585/mmwr.mm6932e2
70. Hanson KE, Caliendo AM, Arias CA, Englund JA, Hayden MK et al. Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19:Serologic Testing. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020;ciaa1343. doi:10.1093/cid/ciaa1343
71. Davies P, Evans C, Kanthimathinathan HK, Lillie J, Brierley J, et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. The Lancet. Child & adolescent health 2020;4(9):669-677. doi:10.1016/S2352-4642(20)30215-7
72. Lee PY, Day-Lewis M, Henderson LA, Friedman KG, Lo J et al. Distinct clinical and immunological features of SARS-CoV-2- induced multisystem inflammatory syndrome in children. The Journal of Clinical Investigation 2020;130(11):5942-5950. doi:10.1172/JCI141113
73. Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE et al. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA 2020;324(3):259-269. doi:10.1001/ jama.2020.10369
74. Kaushik A, Gupta S, Sood M, Sharma S, Verma S. A Systematic Review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection. The Pediatric Infectious Disease Journal 2020;39(11):e340-e346. doi:10.1097/ INF.0000000000002888
75. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C et al. Post-acute COVID-19 syndrome. Nature Medicine 2021;27(4):601-615. doi:10.1038/s41591-021-01283-z
76. Say D, Crawford N, McNab S, Wurzel D, Steer A, Tosif S. Post-acute COVID-19 outcomes in children with mild and asymptomatic disease. The Lancet. Child & Adolescent Health 2021;5(6):e22-e23. doi:10.1016/S2352-4642(21)00124-3
77. Song WJ, Hui CKM, Hull JH, Birring SS, McGarvey L et al. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. The Lancet. Respiratory Medicine 2021;9(5):533-544. doi:10.1016/S2213- 2600(21)00125-9